PAROXETINE AND THE FDA

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 43, Issue 2, 2004, Pages 127-

  Connor, Daniel F ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PAROXETINE;

ADOLESCENT; AUTOMUTILATION; CHEMICALLY INDUCED DISORDER; CHILD; EVIDENCE BASED MEDICINE; FOOD AND DRUG ADMINISTRATION; HUMAN; LETTER; MAJOR DEPRESSION; SUICIDE; UNITED STATES;

ADOLESCENT; ANTIDEPRESSIVE AGENTS; CHILD; DEPRESSIVE DISORDER, MAJOR; EVIDENCE-BASED MEDICINE; HUMANS; PAROXETINE; SELF-INJURIOUS BEHAVIOR; SUICIDE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 1442305257     PISSN: 08908567     EISSN: 15275418     Source Type: Journal    
DOI: 10.1097/00004583-200402000-00001     Document Type: Letter

References (4)

1. FDA Home Page (2003). http:://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01230.html June 19
2. Jureidini J., and Tonkin A. Paroxetine in major depression (letter). J Am Acad Child Adolesc Psychiatry 42 (2003) 514
3. Keller M.B., Ryan N.D., Strober M., et al. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 40 (2001) 762-772
4. Keller M.B., Ryan N.D., Strober M., et al. Paroxetine in major depression, reply (letter). J Am Acad Child Adolesc Psychiatry 40 (2003) 762-772